Gray Peter's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Aug 22, 2022
- Accession no.
- 0001765581-22-000106
- Filed
- Aug 22, 2022
- Trade date
- Aug 18, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.26M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gray PeterCIK 0001576096 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Ordinary Shares | MOption exerciseAcquired | +8,000 | $55.28 | +$442,240 | 22,234 | Direct | |
| Aug 18, 2022 | Ordinary Shares | SSaleDisposed | −8,000 | $158.00 | −$1,264,000 | 14,234 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Ordinary Shares | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.